Pazopanib is a pyrimidine-containing compound that acts as a tyrosine kinase inhibitor and angiogenesis modulating agent. It is used as its hydrochloride salt in pharmaceutical manufacturing as an active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 444731-52-6
Pazopanib hydrochloride
pharmaceutical raw material
Azathioprine
pharmaceutical raw material
Amifampridine phosphate
pharmaceutical raw material
GRF 1-29 (CJC1295)
pharmaceutical raw material
Nylidrin
pharmaceutical raw material
5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
CUIHSIWYWATEQL-UHFFFAOYSA-N
CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N